Title

An Extremely Indolent T-cell Leukemia: An 18-year Follow-Up.

Publication/Presentation Date

2-1-2016

Abstract

T-cell prolymphocytic leukemia (T-PLL) is a rare malignancy that comprises about 2% of all mature lymphoid neoplasms. Patients usually present with prominent peripheral blood lymphocytosis, splenomegaly, hepatomegaly, lymphadenopathy, B symptoms, and occasionally with skin lesions.¹ The disease follows an aggressive clinical course with rapid progression and typically has a median survival of less than 1 year. In some cases, the disease is indolent for a period of time before becoming aggressive.² In 2002, 7 years after initial diagnosis in 1995, the case discussed herein was reported as a rare, indolent form of T-PLL.³ We now present 11 additional years of follow-up of this case, during which time the patient remained asymptomatic with respect to his lymphoid neoplasm.

Volume

14

Issue

2

First Page

76

Last Page

78

ISSN

2330-7749

Disciplines

Hematology | Medical Sciences | Medical Specialties | Medicine and Health Sciences | Oncology

PubMedID

26955661

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Department of Medicine Faculty, Department of Pathology and Laboratory Medicine

Document Type

Article